Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $2.60 billion. The enterprise value is $2.25 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 58.04 million shares outstanding. The number of shares has increased by 1.57% in one year.
| Current Share Class | 58.04M |
| Shares Outstanding | 58.04M |
| Shares Change (YoY) | +1.57% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 4.46% |
| Owned by Institutions (%) | 96.83% |
| Float | 52.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.02 |
| PS Ratio | 3.34 |
| Forward PS | 2.84 |
| PB Ratio | 2.41 |
| P/TBV Ratio | 6.39 |
| P/FCF Ratio | 31.59 |
| P/OCF Ratio | 31.20 |
| PEG Ratio | 0.62 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.39, with an EV/FCF ratio of 27.41.
| EV / Earnings | n/a |
| EV / Sales | 2.90 |
| EV / EBITDA | 18.39 |
| EV / EBIT | 89.06 |
| EV / FCF | 27.41 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.96 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.50 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.75% and return on invested capital (ROIC) is 3.32%.
| Return on Equity (ROE) | -2.75% |
| Return on Assets (ROA) | 1.11% |
| Return on Invested Capital (ROIC) | 3.32% |
| Return on Capital Employed (ROCE) | 2.25% |
| Weighted Average Cost of Capital (WACC) | 7.27% |
| Revenue Per Employee | $998,500 |
| Profits Per Employee | -$37,296 |
| Employee Count | 778 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.94 |
Taxes
| Income Tax | -20.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.20% in the last 52 weeks. The beta is 0.57, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +41.20% |
| 50-Day Moving Average | 49.57 |
| 200-Day Moving Average | 48.95 |
| Relative Strength Index (RSI) | 33.05 |
| Average Volume (20 Days) | 751,512 |
Short Selling Information
The latest short interest is 4.73 million, so 8.15% of the outstanding shares have been sold short.
| Short Interest | 4.73M |
| Short Previous Month | 4.72M |
| Short % of Shares Out | 8.15% |
| Short % of Float | 9.08% |
| Short Ratio (days to cover) | 6.58 |
Income Statement
In the last 12 months, SUPN had revenue of $776.83 million and -$29.02 million in losses. Loss per share was -$0.51.
| Revenue | 776.83M |
| Gross Profit | 575.90M |
| Operating Income | 25.32M |
| Pretax Income | -49.15M |
| Net Income | -29.02M |
| EBITDA | 122.63M |
| EBIT | 25.32M |
| Loss Per Share | -$0.51 |
Full Income StatementBalance Sheet
The company has $384.24 million in cash and $40.90 million in debt, with a net cash position of $343.34 million or $5.92 per share.
| Cash & Cash Equivalents | 384.24M |
| Total Debt | 40.90M |
| Net Cash | 343.34M |
| Net Cash Per Share | $5.92 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 18.55 |
| Working Capital | 357.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $83.26 million and capital expenditures -$1.01 million, giving a free cash flow of $82.25 million.
| Operating Cash Flow | 83.26M |
| Capital Expenditures | -1.01M |
| Depreciation & Amortization | 97.31M |
| Net Borrowing | n/a |
| Free Cash Flow | 82.25M |
| FCF Per Share | $1.42 |
Full Cash Flow StatementMargins
Gross margin is 74.13%, with operating and profit margins of 3.26% and -3.74%.
| Gross Margin | 74.13% |
| Operating Margin | 3.26% |
| Pretax Margin | -6.33% |
| Profit Margin | -3.74% |
| EBITDA Margin | 15.79% |
| EBIT Margin | 3.26% |
| FCF Margin | 10.59% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.57% |
| Shareholder Yield | -1.57% |
| Earnings Yield | -1.12% |
| FCF Yield | 3.17% |
Analyst Forecast
The average price target for SUPN is $62.83, which is 40.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.83 |
| Price Target Difference | 40.37% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 4.78 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.78 |
| Piotroski F-Score | 5 |
